KORU Medical Systems annual gross margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
KORU Medical Systems's gross margin was 62.26% for fiscal 2025.
View full KORU Medical Systems company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 62.26% | −1.14 pp |
| 2024 | 2024-12-31 | 63.40% | +4.81 pp |
| 2023 | 2023-12-31 | 58.59% | +3.50 pp |
| 2022 | 2022-12-31 | 55.09% | −3.52 pp |
| 2021 | 2021-12-31 | 58.62% | −3.16 pp |
| 2020 | 2020-12-31 | 61.78% | −2.35 pp |
| 2019 | 2019-12-31 | 64.13% | +1.83 pp |
| 2018 | 2018-12-31 | 62.29% | +1.16 pp |
| 2017 | 2017-12-31 | 61.13% | −0.44 pp |
| 2016 | 2017-02-28 | 61.57% | −0.51 pp |
| 2015 | 2016-02-29 | 62.08% | +2.60 pp |
| 2014 | 2015-02-28 | 59.47% | −1.57 pp |
| 2013 | 2014-02-28 | 61.04% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 65.14% | +1.62 pp |
| Q1 2026 | 2026-03-31 | 61.47% | −1.29 pp |
| Q4 2025 | 2025-12-31 | 62.57% | −0.37 pp |
| Q3 2025 | 2025-09-30 | 60.22% | −3.17 pp |
| Q2 2025 | 2025-06-30 | 63.52% | −1.48 pp |
| Q1 2025 | 2025-03-31 | 62.75% | +0.50 pp |
| Q4 2024 | 2024-12-31 | 62.94% | +2.67 pp |
| Q3 2024 | 2024-09-30 | 63.40% | +1.40 pp |
| Q2 2024 | 2024-06-30 | 65.00% | +8.94 pp |
| Q1 2024 | 2024-03-31 | 62.25% | +6.15 pp |
| Q4 2023 | 2023-12-31 | 60.27% | +4.74 pp |
| Q3 2023 | 2023-09-30 | 62.00% | +6.31 pp |
| Q2 2023 | 2023-06-30 | 56.06% | +4.94 pp |
| Q1 2023 | 2023-03-31 | 56.10% | −1.91 pp |
| Q4 2022 | 2022-12-31 | 55.53% | −3.51 pp |
| Q3 2022 | 2022-09-30 | 55.70% | −2.17 pp |
| Q2 2022 | 2022-06-30 | 51.11% | −6.96 pp |
| Q1 2022 | 2022-03-31 | 58.01% | −1.50 pp |
| Q4 2021 | 2021-12-31 | 59.04% | +2.41 pp |
| Q3 2021 | 2021-09-30 | 57.87% | −6.94 pp |
| Q2 2021 | 2021-06-30 | 58.07% | −5.62 pp |
| Q1 2021 | 2021-03-31 | 59.51% | −0.34 pp |
| Q4 2020 | 2020-12-31 | 56.62% | −6.82 pp |
| Q3 2020 | 2020-09-30 | 64.81% | −1.42 pp |
| Q2 2020 | 2020-06-30 | 63.69% | −1.29 pp |
| Q1 2020 | 2020-03-31 | 59.85% | −1.43 pp |
| Q4 2019 | 2019-12-31 | 63.44% | −0.09 pp |
| Q3 2019 | 2019-09-30 | 66.23% | +2.64 pp |
| Q2 2019 | 2019-06-30 | 64.98% | +4.13 pp |
| Q1 2019 | 2019-03-31 | 61.27% | +0.14 pp |
| Q4 2018 | 2018-12-31 | 63.53% | −4.63 pp |
| Q3 2018 | 2018-09-30 | 63.59% | +1.80 pp |
| Q2 2018 | 2018-06-30 | 60.85% | +0.86 pp |
| Q1 2018 | 2018-03-31 | 61.14% | +3.37 pp |
| Q4 2017 | 2017-12-31 | 68.17% | +3.53 pp |
| Q2 2017 | 2017-09-30 | 61.79% | −1.31 pp |
| Q1 2017 · Jun 30 | 2017-06-30 | 59.99% | −2.10 pp |
| Q1 2017 · Mar 31 | 2017-03-31 | 57.77% | −6.15 pp |
| Q3 2016 | 2016-11-30 | 64.64% | −0.14 pp |
| Q2 2016 · Sep 30 | 2016-09-30 | 63.11% | +3.54 pp |
| Q2 2016 · Aug 31 | 2016-08-31 | 62.09% | −4.98 pp |
| Q1 2016 · Jun 30 | 2016-06-30 | 63.92% | +0.54 pp |
| Q1 2016 · May 31 | 2016-05-31 | 64.77% | +7.07 pp |
| Q4 2015 | 2016-02-29 | 59.57% | +3.15 pp |
| Q3 2015 | 2015-11-30 | 67.07% | +7.56 pp |
| Q2 2015 | 2015-08-31 | 63.38% | −1.95 pp |
| Q1 2015 | 2015-05-31 | 57.70% | −0.18 pp |
| Q4 2014 | 2015-02-28 | 56.41% | — |
| Q3 2014 | 2014-11-30 | 59.51% | — |
| Q2 2014 | 2014-08-31 | 65.33% | — |
| Q1 2014 | 2014-05-31 | 57.88% | — |
Over the last five reported fiscal years, KORU Medical Systems's gross margin increased from 61.78% to 62.26%, a change of +0.48 percentage points. The latest reported quarter, Q2 2026, shows 65.14%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review KORU Medical Systems filings at SEC.gov ↗